Market Tracker

11/22 5:55am ET

Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

9.20
Delayed Data
As of Nov 21
 -0.21 / -2.23%
Today’s Change
8.14
Today|||52-Week Range
12.30
-11.45%
Year-to-Date
No recent news for Avadel Pharmaceuticals PLC.

Today’s Trading

Previous close9.41
Today’s open9.37
Day’s range9.15 - 9.59
Volume180,812
Average volume (3 months)184,881
Market cap$374.2M
Dividend yield--
Data as of 4:00pm ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)-200.25%
Earnings growth (this year)+595.83%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)-13.04%
P/E ratio4.8
Price/Sales2.86
Price/Book9.20

Competitors

 Today’s
change
Today’s
% change
TLGTTeligent Inc-0.06-1.78%
IOVAIovance Biotherapeut...+0.15+1.81%
TTPHTetraphase Pharmaceu...+0.11+1.74%
DEPODepomed Inc+0.02+0.32%
Data as of 4:00pm ET, 11/21/2017

Financials

Next reporting dateMarch 6, 2018
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$149.8M
Annual profit (last year)-$41.2M
Net profit margin-27.47%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Michael Shannon Anderson
Chief Financial Officer &
Senior Vice President
Michael F. Kanan
Corporate headquarters
Dublin, Dublin

Forecasts